title: Echinacea alkylamides modulate induced immune responses in T-cells.
abstract: The effects of Echinacea and several of its phytochemical components on NFkappaB expression by Jurkat cells (a human T-cell line) were investigated in vitro. In the absence of stimulation, Echinacea and its components exerted no significant effect on basal NFkappaB expression levels. In the presence of endotoxin (LPS), NFkappaB expression was decreased. However, this decrease was significantly reversed by treatment with cichoric acid, an Echinacea root extract (prepared from both Echinacea angustifolia and Echinacea purpurea) and the alkylamide fraction derived from this combination. For the phorbol myristate acetate stimulation of Jurkat cells, effects on NFkappaB expression were mixed. Depending on the concentration, cichoric acid and a 2,4-diene alkylamide significantly induced NFkappaB levels, whereas a 2-ene alkylamide caused a significant inhibition. In contrast, both the Echinacea and the mixed alkylamide fraction exerted no effect. The alkylamide results indicate that the two basic forms of these compounds present in Echinacea may have opposing effects. These opposing effects demonstrate the importance of a knowledge, not only of the phytochemical make-up of a herbal preparation, but also of the actions of each component and the consequences of differing relative amounts in the preparation being investigated.
authors.affiliation: MediHerb Research Laboratories, 3/85 Brandl Street, Eight Mile Plains, Brisbane, Queensland 4113, Australia. amatthias@mediherb.com.au
authors.forename: Anita
authors.initials: A
authors.lastname: Matthias
authors.forename: Linda
authors.initials: L
authors.lastname: Banbury
authors.forename: Kerry M
authors.initials: KM
authors.lastname: Bone
authors.forename: David N
authors.initials: DN
authors.lastname: Leach
authors.forename: Reg P
authors.initials: RP
authors.lastname: Lehmann
mesh_terms: D002109:Caffeic Acids / Q000494:pharmacology*; D002273:Carcinogens; D020900:Echinacea / Q000737:chemistry*; D006801:Humans; D019169:Jurkat Cells; D008070:Lipopolysaccharides / Q000276:immunology / Q000494:pharmacology; D016328:NF-kappa B / Q000187:drug effects* / Q000276:immunology; D010936:Plant Extracts / Q000494:pharmacology*; D018517:Plant Roots; D053284:Polyunsaturated Alkamides / Q000494:pharmacology*; D013386:Succinates / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D013755:Tetradecanoylphorbol Acetate / Q000276:immunology / Q000494:pharmacology
chemical_list: D002109:Caffeic Acids; D002273:Carcinogens; D008070:Lipopolysaccharides; D016328:NF-kappa B; D010936:Plant Extracts; D053284:Polyunsaturated Alkamides; D013386:Succinates; D013755:Tetradecanoylphorbol Acetate; C100435:chicoric acid